A Study of LY317615 in Patients With Brain Tumors

• Status: Completed
• Trial end date: 2006-12-01

Summary

1. The safety of LY317615 and any side effects that might be associated with the drug.

2. Whether LY317615, can help patients with brain tumors.

• Phase: Phase 2

Details

• Lead Sponsor: Eli Lilly and Company